DEXCOM INC (DXCM)
Surgical & Medical Instruments & Apparatus · Healthcare · $28.2B
Intrinsic Value (Consensus)
$26.79
Current Price
$73.16
Margin of Safety
-63.4%
63.4% Above Intrinsic Value
Value: $27
Price: $73
Valuation Model Estimates
Current Price: $73.16
DCF (Discounted Cash Flow)
$130.90
Graham Number
$18.29
Earnings Power Value
$20.29
Relative Value (P/E)
$41.80
Dividend Discount Model
Not applicable
—
Consensus Value
$26.79
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
75
Profitability
25/25
Strength
24/25
Valuation
7/25
Growth
19/25
Financial Health Signals
Strong profitability — ROE of 30% (above 20% is excellent)
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $2.09
- EPS (Forward)
- $2.51
- Book Value
- $7.12
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 30.5%
- Debt/Equity
- 0%
- Revenue Growth
- 15.6%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance